← Leaderboards
Andrew Michael Dylag
University Of Rochester
$648,564
Attributed
$648,564
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $162.1K · FY2022–25$200K$150K$100K$50K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$648,564 · 1
By mechanism
K08$648,564 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Rochester
Same institution · by research overlap
- Craig N Morrell$13,426,108
- Michael A O'Reilly$17,416,994
- Richard P. Phipps$12,624,990
- Jacob N Finkelstein$12,366,070
- James Palis$20,960,389
Others in their field
Other Rising Stars on “Affect”
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Thomas K Karikari · Wake Forest University Health Sciences$14,340,584
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Brian Todd Schaneberg · Illinois Institute Of Technology$13,469,813
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
Research focus
AffectAirway DiseaseAirway HyperresponsivenessAntibodiesAutopsyAwardBioinformaticsBirthBlood PlateletsBone MarrowBreathingBronchopulmonary DysplasiaCareerCareer DevelopmentCaringCell LineageCellsChildhoodCytokineDesignDevelopment PlansDoseEarly ChildhoodAdult
Grant awards (4)
The Role of Lung Megakaryocytes in Airway Disease after Neonatal Hyperoxia$162,141
K08 · FY2025 · HL · contact PI
The Role of Lung Megakaryocytes in Airway Disease after Neonatal Hyperoxia$162,141
K08 · FY2024 · HL · contact PI
The Role of Lung Megakaryocytes in Airway Disease after Neonatal Hyperoxia$162,141
K08 · FY2023 · HL · contact PI
The Role of Lung Megakaryocytes in Airway Disease after Neonatal Hyperoxia$162,141
K08 · FY2022 · HL · contact PI